Why cure, why now?
View/ Open
Author
Published Version
https://doi.org/10.1136/medethics-2015-103113Metadata
Show full item recordCitation
Kuritzkes, Daniel R. 2017. “Why cure, why now?” Journal of Medical Ethics 43 (2): 67-70. doi:10.1136/medethics-2015-103113. http://dx.doi.org/10.1136/medethics-2015-103113.Abstract
Combination antiretroviral therapy (cART) is highly effective at preventing morbidity and mortality due to infection with human immunodeficiency virus (HIV), but does not eradicate the virus. Consequently, cART must be administered life-long. Recent progress has stimulated research towards a cure of HIV infection. Approaches under investigation include hematopoietic stem cell transplantation, latency reactivating agents, immune based therapies, and cell-based therapies. Each of these approaches carries potential risks that must be weighed against the availability of safe and effective cART. Balancing the risks and benefits of this research poses unique challenges to potential study participants, clinicians and investigators.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293855/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731764
Collections
- HMS Scholarly Articles [17921]
Contact administrator regarding this item (to report mistakes or request changes)